Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Preferred Stock Liabilities (2016 - 2021)

Updated

Vistagen Therapeutics (VTGN) recorded Preferred Stock Liabilities of $1,100 in fiscal Q2 2022 (quarter ended Sep 30, 2021).

Analysis

Vistagen Therapeutics (VTGN) Preferred Stock Liabilities (2016 - 2021) Analysis & Trends

At the end of FY2016 (ended Mar 31, 2016), Vistagen Therapeutics reported Preferred Stock Liabilities of $2,300.

  • The fiscal Q2 2022 figure is the highest quarterly Preferred Stock Liabilities since fiscal Q3 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn -
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn -
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn -
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn -
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn -
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn -
9 Gsk 193.54 Bn 176.38 Bn - -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 1,100.00
Dec 31, 2017 1,200.00
Jun 30, 2017 1,200.00
Mar 31, 2016 2,300.00
API Access

Vistagen Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=VTGN&period=max&api_key=YOUR_API_KEY